NASDAQ:NERV
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. reported net income of −$293.4M in fiscal 2025. The diluted share count rose 11.7%.Summary generated from Minerva Neurosciences, Inc.'s SEC filings. Latest annual report filed Mar 11, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+11.7%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | n/a |
| Operating income | −45 | −25 | −23 | −22 | −15 |
| Net income | −50 | −32 | −30 | 1 | −293 |
| Free cash flow | n/a | −25 | n/a | n/a | n/a |
Recent filings
- 8-KDirector or officer change
Aug 12, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 8-KResults of operations and financial condition
Aug 7, 2026 - 4Insider transaction report
Aug 3, 2026 - 4Insider transaction report
Jun 5, 2026 - 8-KAmendment to articles or bylaws
Jun 4, 2026 - 8-KEntry into a material agreement
May 27, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 5, 2026